The effect of sulfation of alginate hydrogels on the specific binding and controlled release of heparin-binding proteins

被引:269
作者
Freeman, Inbar [1 ]
Kedem, Alon [1 ]
Cohen, Smadar [1 ]
机构
[1] Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel
基金
以色列科学基金会;
关键词
affinity binding; biomimetics; angiogenesis; bFGF; hyaluronic acid; sulfation of polysaccharides;
D O I
10.1016/j.biomaterials.2008.04.025
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
To mimic the high affinity of heparin-binding proteins to heparin/heparan sulfate, the uronic acids in non-sulfated alginate were sulfated, and hydrogels of mixed alginate/alginate-sulfate were fabricated. Surface plasmon resonance analysis probed the interactions of 13 proteins with alginate-sulfate. Of these, the 10 heparin-binding proteins revealed strong binding to alginate-sulfate and heparin, but not to alginate. The equilibrium binding constants to alginate-sulfate were comparable or one order of magnitude higher than those obtained between the proteins and heparin. Only the fibroblast growth factors (FGFs) revealed higher affinity for heparin than to alginate-sulfate. Sulfation of hyaluronan, as well, resulted in strong binding of basic FGF to hyaluronan-sulfate, but not to hyaluronan. Mixed hydrogels of alginate/alginate-sulfate sustained the release of basic FGF, with the release rate being dependent on the percentage of bFGF bound to the hydrogels. In vivo, the delivery of bFGF bound to alginate/alginate-sulfate scaffolds induced the formation of twice the number of blood vessels compared to when bFGF was delivered adsorbed to the matrix and 51% of the vessels were matured, as judged by pericyte coverage of the vessels. Our results thus describe the engineering of alginate hydrogels for the spatially presentation and controlled delivery of heparin-binding proteins. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3260 / 3268
页数:9
相关论文
共 27 条
[1]   Stromal cell-derived factor-1α associates with heparan sulfates through the first β-strand of the chemokine [J].
Amara, A ;
Lorthioir, O ;
Valenzuela, A ;
Magerus, A ;
Thelen, M ;
Montes, M ;
Virelizier, JL ;
Delepierre, M ;
Baleux, F ;
Lortat-Jacob, H ;
Arenzana-Seisdedos, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (34) :23916-23925
[2]  
Bock R., 1979, A Handbook of Decomposition Methods in Analytical Chemistry
[3]   Structure and biological interactions of heparin and heparan sulfate [J].
Casu, B ;
Lindahl, U .
ADVANCES IN CARBOHYDRATE CHEMISTRY AND BIOCHEMISTRY, VOL 57, 2001, 57 :159-206
[4]   STRATEGIES TO SUPPRESS AGGREGATION OF RECOMBINANT KERATINOCYTE GROWTH-FACTOR DURING LIQUID FORMULATION DEVELOPMENT [J].
CHEN, BL ;
ARAKAWA, T ;
HSU, E ;
NARHI, LO ;
TRESSEL, TJ ;
CHIEN, SL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 83 (12) :1657-1661
[5]   PERIVASCULAR AND INTRAVENOUS ADMINISTRATION OF BASIC FIBROBLAST GROWTH-FACTOR - VASCULAR AND SOLID ORGAN DEPOSITION [J].
EDELMAN, ER ;
NUGENT, MA ;
KARNOVSKY, MJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (04) :1513-1517
[6]   High-affinity binding of basic fibroblast growth factor and platelet-derived growth factor-AA to the core protein of the NG2 proteoglycan [J].
Goretzki, L ;
Burg, MA ;
Grako, KA ;
Stallcup, WB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (24) :16831-16837
[7]   HEPARIN PROTECTS BASIC AND ACIDIC FGF FROM INACTIVATION [J].
GOSPODAROWICZ, D ;
CHENG, J .
JOURNAL OF CELLULAR PHYSIOLOGY, 1986, 128 (03) :475-484
[8]   Sustained delivery of vascular endothelial growth factor with alginate beads [J].
Gu, F ;
Amsden, B ;
Neufeld, R .
JOURNAL OF CONTROLLED RELEASE, 2004, 96 (03) :463-472
[9]   Preparation of low-molecular weight alginic acid by acid hydrolysis [J].
Ikeda, A ;
Takemura, A ;
Ono, H .
CARBOHYDRATE POLYMERS, 2000, 42 (04) :421-425
[10]   The analysis of heparin-protein interactions using evanescent wave biosensor with regioselectively desulfated heparins as the ligands [J].
Kamei, K ;
Wu, XF ;
Xu, XY ;
Minami, K ;
Huy, NT ;
Takano, R ;
Kato, H ;
Hara, S .
ANALYTICAL BIOCHEMISTRY, 2001, 295 (02) :203-213